CLISTIN Drug Patent Profile
✉ Email this page to a colleague
When do Clistin patents expire, and what generic alternatives are available?
Clistin is a drug marketed by Mcneil and Ortho Mcneil Pharm and is included in two NDAs.
The generic ingredient in CLISTIN is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clistin
A generic version of CLISTIN was approved as carbinoxamine maleate by GENUS on March 19th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLISTIN?
- What are the global sales for CLISTIN?
- What is Average Wholesale Price for CLISTIN?
Summary for CLISTIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Patent Applications: | 1,314 |
| DailyMed Link: | CLISTIN at DailyMed |
US Patents and Regulatory Information for CLISTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mcneil | CLISTIN | carbinoxamine maleate | ELIXIR;ORAL | 008955-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Ortho Mcneil Pharm | CLISTIN | carbinoxamine maleate | TABLET;ORAL | 008915-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
